News Image

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

Provided By GlobeNewswire

Last update: Aug 11, 2023

- Activated CHORDTM clinical trial sites in U.S., U.K. and Spain and commenced patient screening activities; anticipate dosing first patient in the Phase 1/2 clinical trial in the second half of 2023 -

Read more at globenewswire.com
Follow ChartMill for more